AZD1981 + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Moderate to Severe COPD
Conditions
Moderate to Severe COPD
Trial Timeline
May 1, 2008 → Dec 1, 2008
NCT ID
NCT00690482About AZD1981 + Placebo
AZD1981 + Placebo is a phase 2 stage product being developed by AstraZeneca for Moderate to Severe COPD. The current trial status is completed. This product is registered under clinical trial identifier NCT00690482. Target conditions include Moderate to Severe COPD.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02031679 | Phase 2 | Completed |
| NCT00766415 | Phase 2 | Completed |
| NCT00690482 | Phase 2 | Completed |
Competing Products
20 competing products in Moderate to Severe COPD